Generic Industry Hit With Avalanche Of Price Fixing Suits

As state attorneys general and Department of Justice move against generic manufacturers, plaintiffs’ firms have filed more than 90 antitrust suits on behalf of third party payers.

court house

The pressure on generic drug manufacturers is intensifying as investigations by the Department of Justice and state attorneys general have resulted in criminal charges against two former executives and the first government complaint alleging six firms conspired to raise prices and allocate markets.

While drug companies have faced antitrust claims in the past over so-called pay-for-delay deals and product hopping, this is a...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Pricing Debate

More from Market Access